Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 4
1991 1
1992 3
1993 1
1994 3
1995 3
1996 3
1997 3
1998 6
1999 10
2000 5
2001 13
2002 10
2003 11
2004 14
2005 22
2006 16
2007 12
2008 10
2009 11
2010 7
2011 10
2012 4
2013 12
2014 7
2015 5
2016 14
2017 26
2018 27
2019 26
2020 31
2021 36
2022 38
2023 30
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

399 results

Results by year

Filters applied: . Clear all
Page 1
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.
Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Yoshiji H, et al. J Gastroenterol. 2021 Jul;56(7):593-619. doi: 10.1007/s00535-021-01788-x. Epub 2021 Jul 7. J Gastroenterol. 2021. PMID: 34231046 Free PMC article. Review.
Treatment for cirrhotic ascites.
Kawaratani H, Fukui H, Yoshiji H. Kawaratani H, et al. Among authors: yoshiji h. Hepatol Res. 2017 Feb;47(2):166-177. doi: 10.1111/hepr.12769. Epub 2016 Jul 27. Hepatol Res. 2017. PMID: 27363974 Review.
Role of serum albumin in hepatic encephalopathy.
Akahane T, Yoshiji H. Akahane T, et al. Among authors: yoshiji h. Hepatol Res. 2021 Apr;51(4):353-354. doi: 10.1111/hepr.13632. Hepatol Res. 2021. PMID: 33797845 No abstract available.
Non-invasive tests for clinically significant portal hypertension after HCV cure.
Semmler G, Lens S, Meyer EL, Baiges A, Alvardo-Tapias E, Llop E, Tellez L, Schwabl P, Mauro E, Escudé L, Díez C, Ibañez-Samaniego L, Puente Á, Fortea JI, Abadía M, Zanetto A, Conthe A, Hernandez-Évole H, Luzko Scheid IS, Jia J, Yoshiji H, Francque SM, Tsochatzis EA, Russo FP, Crespo G, Forns X, Bañares R, Villanueva C, Hernández-Gea V, Reiberger T, Bosch J, García Pagán JC, Mandorfer M; A study by the Baveno Cooperation: an EASL consortium. Semmler G, et al. Among authors: yoshiji h. J Hepatol. 2022 Dec;77(6):1573-1585. doi: 10.1016/j.jhep.2022.08.025. Epub 2022 Sep 5. J Hepatol. 2022. PMID: 36063968 Free article.
[Current drug therapy for hepatocellular carcinoma].
Yoshiji H. Yoshiji H. Nihon Shokakibyo Gakkai Zasshi. 2022;119(5):389-402. doi: 10.11405/nisshoshi.119.389. Nihon Shokakibyo Gakkai Zasshi. 2022. PMID: 35545537 Japanese. No abstract available.
Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice.
Iwai S, Kaji K, Nishimura N, Kubo T, Tomooka F, Shibamoto A, Suzuki J, Tsuji Y, Fujinaga Y, Kitagawa K, Namisaki T, Akahane T, Yoshiji H. Iwai S, et al. Among authors: yoshiji h. Biochim Biophys Acta Mol Basis Dis. 2023 Oct;1869(7):166770. doi: 10.1016/j.bbadis.2023.166770. Epub 2023 Jun 3. Biochim Biophys Acta Mol Basis Dis. 2023. PMID: 37276988
399 results